LIMN

Liminatus Pharma, Inc. Class A Common Stock NASDAQ Listed May 1, 2025

Healthcare ·Biotechnology ·US · liminatuspharma.com

$0.20

Mkt Cap $5.4M

52w Low $0.16 0.1% of range 52w High $33.66

50d MA $0.21 200d MA $1.45

P/E (TTM) -0.5x

EV/EBITDA -1.6x

P/B —

Debt/Equity -0.1x

ROE 104.0%

P/FCF -1.5x

RSI (14) —

ATR (14) —

Beta 0.63

50d MA $0.21

200d MA $1.45

Avg Volume 11.6M

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

CIK (SEC)

1971387

Phone

213 273 5453

6 Centerpointe Drive · La Palma, CA 90623 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 31, 2026	AMC	—	-0.03	—	0.17	+0.1%	-0.5%	+2.3%	+6.6%	-1.1%	-0.3%	—
Nov 13, 2025	AMC	—	-0.07	—	1.07	-4.7%	+0.0%	-0.9%	+4.7%	+0.9%	-6.2%	—
Oct 3, 2025	AMC	—	-0.05	—	1.73	+1.7%	+0.0%	-8.7%	+1.3%	-4.4%	-7.8%	—

Data updated apr 25, 2026 7:13pm · Source: massive.com